Blog

The high street wellness phenomenon represents a fundamental structural transformation of England’s town and city centres, shifting the core economic function from cyclical, transactional retail toward resilient, service-based, and experience-led health and wellbeing offerings. This transition is not merely cosmetic; it is driven by powerful macroeconomic forces, notably the structural resilience of the self-pay health consumer and targeted government intervention aimed at high street revitalisation. &nbsp;&nbsp; This analysis confirms the viability of High Street Wellness as an investment theme. High covenant, service-led operators, spanning clinical services, premium fitness and specialised beauty, are actively displacing traditional retail. This trend supports premium rental yields and robust asset valuation, particularly in prime London locations, which are seeing rents for specialised F&amp;B and wellness venues achieve £100–£150 per square foot annually. &nbsp;&nbsp; However, the market performance is highly stratified. Success directly correlates with local economic resilience, specifically high disposable income and favourable demographic profiles, particularly in Gen Z-led cities that prioritise experiential spending. The primary risk lies in generalised deployment across vulnerable, retail-dependent towns. Strategic capital must be directed toward integrated, technologically advanced service models within mixed use developments, leveraging the crucial alignment between commercial viability and public health policy, as outlined in the ‘Healthy High Streets’ mandate.High Street Wellness is defined by the physical manifestation of convergence across several sectors: preventative health, specialized beauty, bespoke fitness and supplementary secondary care services situated within traditional town centres. This evolution signifies a deep, structural transition within the commercial property landscape, fundamentally moving beyond transactional commerce to personalised, service based and experience focused consumer interactions. This model emphasizes customer longevity and high engagement over fleeting retail purchases. &nbsp;This shift holds critical implications for town planning and public policy. Local authorities and public health experts now recognise that the high street environment is highly influential in shaping overall health outcomes, acting as a crucial location where communities work, live, meet and consume. The recognition of high streets as social and environmental determinants of health has prompted policies explicitly focused on revitalising these areas. &nbsp;&nbsp; A key requirement for this revitalisation is the mixed use imperative. Policy actively promotes the development of mixed-use streets that combine commercial, residential, cultural, leisure, and service industries. This multi-functional approach is supported by evidence demonstrating that it encourages essential health determinants, including footfall, active travel (walking and cycling) and social interaction, which helps to build social capital and reduce isolation.Local decision-makers, including public health professionals and town managers, are officially advised to promote and support such mixed-use developments to enhance community well-being.The High Street Wellness movement in England is not a cyclical retail fad but a permanent, structural convergence of the retail and healthcare asset classes, driven by fundamental shifts in consumer values and healthcare provision. The demonstrable growth of the self-pay market (+38% self-pay admissions since 2019) validates the consumer's essentialisation of wellness expenditure. &nbsp;By strategically allocating capital based on economic resilience (local income), demographic drivers (Gen Z experience demand), and strict adherence to the scalable operational requirements (integration, consistency), investors can secure assets that offer superior covenant strength and attractive yields. The successful High Street Wellness asset anchors the new service-led urban economy and aligns commercial viability with the sustainable goals of the Wellbeing Economy.Source: <a data-mce-href="https://www.healthcare.digital/single-post/high-street-wellness-and-private-health-consumers-emerging-new-trend-for-2026" href="https://www.healthcare.digital/single-post/high-street-wellness-and-private-health-consumers-emerging-new-trend-for-2026" title="https://www.healthcare.digital/single-post/high-street-wellness-and-private-health-consumers-emerging-new-trend-for-2026" target="_blank" rel="noopener">https://www.healthcare.digital/single-post/high-street-wellness-and-private-health-consumers-emerging-new-trend-for-2026</a>To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

High Street Wellness: Emerging New Trend for 2026

Nelson Advisors has been invited to join the 'Startups and Corporates: How to Build Meaningful Partnerships in MedTech' panel at MedTech Europe 2025. Nelson Advisors Partner Lloyd Price will join fellow panellists including: &nbsp;&nbsp; NICOLE BLACK, Program Director, MedTech Innovator &nbsp;&nbsp; KHURRAM MIR, Managing Director, UCI Health &nbsp;&nbsp; DAVID UFFER, Managing Director, Medtech, Trinity Life Sciences &nbsp;&nbsp; SANJAY SHRIVASTAVA, PH.D, CEO and Founder, Innova Vascular, Inc &nbsp;&nbsp; OSAMA ALSALEH, Head of Partnerships, Health, Plug and PlayThe focus of the panel will be a discussion on creating successful collaborations between startups and corporates, focusing on alignment, trust, and shared value to accelerate MedTech innovation.MedTech Malta 2025 &nbsp;&nbsp; The MedTech Malta 2025 event is a three-day summit scheduled to take place from November 12-14, 2025, at the Mediterranean Conference Centre in Valletta, Malta. 🇲🇹 &nbsp;&nbsp; What to Expect at MedTech Malta 2025 &nbsp;&nbsp; The conference is a convergence point for a global audience, including investors, entrepreneurs and healthcare leaders. It aims to foster collaboration and showcase the latest advancements in medical technology. The agenda includes: &nbsp;&nbsp; Panel Discussions &amp; Keynotes: featuring experts from various fields within the MedTech ecosystem. Startup Pitch Competitions: offering a platform for emerging companies to showcase their innovations. Exhibitions: with a focus on cutting-edge technologies. Networking Opportunities: including exclusive forums for CEOs and investors. Cultural Activities &amp; Awards Gala: the event is set against the backdrop of Malta's historic capital, with a cultural tour and the prestigious MedTech World Awards Ceremony. The conference is a CPD-accredited event, providing healthcare professionals with an opportunity for professional development. &nbsp;&nbsp; <a data-mce-href="https://med-tech.world/malta/" href="https://med-tech.world/malta/" title="https://med-tech.world/malta/" target="_blank" rel="noopener">https://med-tech.world/malta/</a>

Nelson Advisors at MedTech Europe 2025

The 4 A's of healthcare AI—Augment, Adopt, Align, and Adapt, represent a framework focused on ensuring that the development and deployment of Artificial Intelligence in healthcare is effective, ethical, and centered on human needs. This framework, particularly promoted by organisations focusing on behavioural science in AI, can be applied to many sectors, including healthcare.🧠 The 4 A's of Healthcare AI Here is a breakdown of what each 'A' typically addresses in the context of AI and human behaviour, especially in a sensitive sector like healthcare:1. Augment: This principle focuses on how AI can enhance and extend human capabilities rather than replacing them. In healthcare, it emphasises the concept of "Augmented Intelligence," meaning AI tools should support clinicians by improving diagnostic accuracy, personalising treatment, reducing administrative burdens, and accelerating research, while still keeping human oversight, empathy and judgment central to care.2. Adopt: This addresses the practical challenge of getting individuals and organizations to use AI effectively. It requires understanding the human factors, what motivates healthcare professionals and institutions to use or resist AI and designing systems and workflows that encourage meaningful uptake and deep integration of the technology into clinical practice, moving beyond simple, shallow use.3. Align: This critical component ensures that AI systems are designed to fit human psychology, behavior, and values. In healthcare, this means developing AI that is:Trustworthy (reliable, safe, and transparent). Ethical (free from bias and protecting patient privacy). Consistent with the goal of patient-centered care. Alignment involves embedding explainability and interpretability into the AI's core architecture. 4. Adapt: This looks at the systemic and societal changes necessary to accommodate the widespread use of AI. For healthcare, this involves:Updating regulations and governance structures. Evolving professional roles and training (e.g., ensuring clinicians maintain core skills while learning to work effectively with AI). Preparing the entire healthcare system and public to manage the new ethical and operational challenges AI presents. This framework shifts the focus from purely technical capabilities to the holistic integration of AI within human systems, which is vital for high-stakes environments like medicine.To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

The 4 A's of Healthcare AI

Nelson Advisors Partner Lloyd Price has been invited to Judge the PitchFest Awards at ReWired 2026. This is the 3rd time Lloyd has Judged the prestigious awards, highlighting the pedigree of UK Digital Health and MedTech companies. &nbsp;&nbsp; PitchFest Awards at ReWired 2026 &nbsp;&nbsp; The PitchFest Awards at ReWired 2026 is the final stage of the UK's most high-profile digital health start-up competition, organised as part of the annual Digital Health Rewired conference and exhibition. It provides a platform for innovators to pitch their solutions to influential leaders, investors, and NHS digital teams. The competition follows a phased process to select the final winners: &nbsp; Application: Start-ups submit their proposals. The deadline for 2026 applications is 21 November 2025. Virtual Heats: Shortlisted contestants pitch their solutions virtually to a panel of judges from the NHS, venture capitalists, and digital health accelerators. Live Final: The top finalists compete live on stage at the Rewired conference. &nbsp;&nbsp; <a data-mce-href="https://digitalhealthrewired.com" href="https://digitalhealthrewired.com" title="https://digitalhealthrewired.com" target="_blank" rel="noopener">https://digitalhealthrewired.com</a> &nbsp;&nbsp; Winner's Prize &nbsp;&nbsp; The winners receive significant support and exposure, most notably: &nbsp;&nbsp; Pilot Opportunity: Expert advice and the potential to run a real-world project within the Chelsea and Westminster Hospital NHS Foundation Trust, delivered through the CW Innovation Team and Pitchfest partner CW+. Visibility: Free entry to Rewired 2026 and features on Digital Health News. &nbsp;&nbsp; The competition often includes separate categories for pre-revenue and revenue-generating start-ups. Past winners have achieved significant growth and secured funding within the NHS and international markets. &nbsp;&nbsp; <a data-mce-href="https://digitalhealthrewired.com/pitchfest" href="https://digitalhealthrewired.com/pitchfest" title="https://digitalhealthrewired.com/pitchfest" target="_blank" rel="noopener">https://digitalhealthrewired.com/pitchfest</a>

Nelson Advisors invited to Judge the Digital Health PitchFest Awards 2026

November 2025 Calendar On Blue Background

There has been a dynamic mix of significant funding, major EU policy initiatives, and next-generation technology integration in European HealthTech this week. The sector is clearly shifting towards scaling proven digital models and leveraging deep tech like AI and Extended Reality (XR).🚀 Major European HealthTech Developments1. Significant Funding and Investor FocusLargest-Ever Spanish Eldercare Round: The Spanish HealthTech startup Qida secured a massive €37 million in fresh funding. This marks the largest investment round ever in the elder-care sector in Spain, highlighting a strong and growing investor appetite for scalable, tech-enabled home and long-term care models across Europe. Deep-Tech and AI Investment: Investor commentary from major conferences emphasized a strategic shift toward funding technologies that create long-term value and economic resilience. AI is noted to be transitioning from horizontal platforms to specialized industry verticals, with healthcare being a key target sector where unique data creates a competitive advantage. Funding Strength: While global digital health funding has faced headwinds, Europe has been a notable exception, recently capturing a record share of global funding with a strong preference for later-stage ventures that can demonstrate clinical validation and clear pathways to revenue. &nbsp; 2. EU Policy and Digital Transformation InitiativesThe European Union continues to focus heavily on foundational digital infrastructure and skills: Focus on AI Adoption (Apply AI Strategy): The European Commission is moving forward with its 'Apply AI Strategy,' which aims to accelerate the practical use of AI across key industries, including health. This is part of the broader effort to close Europe's "AI adoption gap" by transitioning AI from research into routine services. New Innovation Act Proposed: Plans are being set out for an EU Innovation Act to bolster technological sovereignty. Key components relevant to HealthTech include: Introducing EU-level definitions for startups and scale-ups to better target support. Establishing common rules for Regulatory Sandboxes to allow innovative health technologies to be tested in a real-world environment across member states with regulatory oversight. Boosting Digital Health Literacy: An upcoming European Digital Health Literacy Conference highlights the critical need to equip citizens, patients, and healthcare professionals with the necessary skills to fully benefit from digital health services, recognizing that literacy is key to successful digital transformation. &nbsp; 3. Next-Generation Technology in Practice Extended Reality (XR) in Education: The EU launched the LEAPXR project, an innovative research initiative to revolutionize healthcare education and research using Extended Reality (XR) technologies. This project, which secured a €1.3 million investment, aims to create immersive simulations for training healthcare professionals, improving learning outcomes, and strengthening the quality of patient care. Virtual Human Twins (VHT) Initiative: The European Commission is pushing forward its strategic vision for the European Virtual Human Twins (VHT) Initiative, a major step towards making personalized medicine a reality through advanced AI modeling. These developments show a maturing HealthTech ecosystem that is heavily supported by strategic European funding and policy, focusing on both the cutting-edge (AI, XR) and the foundational (regulatory reform, digital skills).&gt;&gt;&nbsp;This week in European MedTech was dominated by significant regulatory developments, especially in the UK, alongside notable AI-focused product news and market concerns about global trade issues. 1. Regulatory Updates and Calls for Reform The most prominent news revolves around regulatory frameworks in both the EU and the UK: MedTech Europe Urges Regulatory Overhaul: The trade group, backed by numerous national associations, has renewed its call for the European Commission to significantly improve the global competitiveness of the regulatory pathway for medical technologies (MDR/IVDR). Key requests include: Short-Term Relief: Targeted postponement of re-certification requirements for already-certified devices to prevent a market bottleneck. Longer-Term Reform: Establishing a single, accountable governance structure for Notified Bodies and accelerating the development of regulatory pathways for breakthrough and orphan/paediatric devices. Mandatory Incident Reporting Form Update: The new Manufacturer Incident Report (MIR form, version 7.3.1) is set to become mandatory in November 2025 for all serious incident reporting under the EU MDR and IVDR. This is a crucial update for manufacturers' post-market surveillance (PMS) processes. UK MHRA Rare Disease Reform: The UK's MHRA has committed to a major reform of rare disease therapy regulation. This initiative aims to increase access to treatments for the vast majority of rare diseases that currently lack approved therapies, potentially leveraging real-world data, AI/ML models, and in-silico trials for evidence generation. &nbsp; 2. Innovation, Funding, and Product Launches AI in Healthcare: The European Commission is moving forward with its "Apply AI Strategy," which aims to boost AI adoption across strategic sectors, with healthcare, pharmaceuticals, and medical devices specifically covered. Product Launches &amp; Milestones: Medtronic launched its VitalFlow ECMO system in Europe, a new one-system platform for critical care patient support. Vektor Medical secured the CE mark for its AI-assisted, non-invasive arrhythmia mapping product, vMap, opening its entry into the EU market. Quantum Surgical received a CE mark for an indication expansion to treat bone tumors/metastases with its Epione® robotic system. Funding Rounds: There's continued investment in the sector, with notable funding for companies in areas like neurostimulation (e.g., ONWARD Medical's private placement) and women's health discovery (e.g., Cyclana Bio's pre-seed round for endometriosis research). &nbsp; 3. Industry Events &amp; Focus Areas Cybersecurity Focus: Cybersecurity for medical devices remains a hot topic, especially regarding compliance with both FDA and EU MDR/IVDR requirements. This is highlighted by the upcoming MedTech World Malta 2025 conference. Robotics in Healthcare: A new study on 'Robotics in Healthcare' was published, underscoring the rapid development and diverse applications of medical robotics, which will be a key discussion point at the upcoming MEDICA 2025 trade fair.To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener">lloyd@nelsonadvisors.co.uk</a>

This Week in European HealthTech and MedTech: 7th November 2025

Event Details &nbsp;&nbsp; Date: Tuesday, November 18, 2025 &nbsp;&nbsp; Location: Havas Kings Cross Building, London &nbsp;&nbsp; Host: WellFounded (Founders Health &amp; Concierge Performance Medicine) &nbsp;&nbsp; Access: By invitation/application only (free for invited guests/applicants) &nbsp;&nbsp; Source: <a data-mce-href="https://wellfounded.health/summit-schedule" href="https://wellfounded.health/summit-schedule" title="https://wellfounded.health/summit-schedule" target="_blank" rel="noopener">https://wellfounded.health/summit-schedule</a> &nbsp;&nbsp; Core Theme &nbsp;&nbsp; The overarching question driving the Summit is: "Can Precision Breakthroughs, Regulatory Revolution &amp; AI (Re)Humanise Healthcare?" The goal is to explore how to "Make medicine personable again." Key Areas of Focus (The Deeper Shift) &nbsp;&nbsp; The summit is dedicated to exploring the fundamental reimagining of medicine around the individual, moving beyond just diagnostics and treatment. The topics include: &nbsp;&nbsp; Direct-to-Customer Preventive Services: Exploring the business models and innovations in consumer health that are attracting significant investment and moving care away from traditional clinical settings.Concierge Practices &amp; Human-Centred Care: Discussing new models of healthcare delivery that promise deeply personalised, high-touch, human-centred care.Longevity Clinics: Examining the radically tailored pathways and scientific developments offered by longevity and healthspan clinics.AI Redefining Medicine: Analysing how Artificial Intelligence is fundamentally changing the way patients and clinicians interact with medicine.The Fifth 'P': Personable: Moving beyond Professor Leroy Hood's "4P's" (Proactive, Precise, Preventive, Personalised) to address the need to make healthcare truly Personable. Critical Debates The Summit will also delve into the complexities and challenges of this transformation, with provocations such as: &nbsp;&nbsp; Is AI an efficiency tool that buys the profession more time, or is it dissolving the essential clinician–patient bond?Are customised therapies, biotech breakthroughs, and loosely regulated trials truly testable and scalable for the wider population?The event is designed to bring a "human lens" to the future of healthcare, from hyper-targeted treatments to achieving human flourishing.

Nelson Advisors

Blog

High Street Wellness: Emerging New Trend for 2026

Nelson Advisors at MedTech Europe 2025

The 4 A's of Healthcare AI

Nelson Advisors invited to Judge the Digital Health Pitch...

This Week in European HealthTech and MedTech: 7th Novembe...

Nelson Advisors invited to join the 'Business Case for Ul...